Research Footnotes

Patients Page

  1. What does the history of Australian cannabis policy suggest about its likely future shape? Wayne D. Hall, The University of Queensland Centre for Clinical Research
  2. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42:327–360
  3. Pharmaceuticals G. Sativex product monograph. 2010.

Healthcare Professionals Portal

  1. ElSohly, M.A., and W. Gul. 2014. Constituents of cannabis sativa. In Handbook of Cannabis. Oxford, UK: Oxford University Press. P. 20.
  2. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990; 346:561–564. doi: 10.1038/346561a0.
  3. Pertwee, R.G. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin. NCBI Link.
  4. FDA Approves First Drug Comprised of Marijuana As Active Ingredient. FDA Link.
  5. Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients. NCBI Link.
  6. Does Cannabidiol Protect Against Adverse Psychological Effects of THC? NCBI Link.
  7. Qualifying Conditions of Medical Cannabis License Holders in the United States. NCBI Link.
  8. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Chapter 4 Therapeutic Effects of Cannabis and Cannabinoids. NCBI Link.
  9. Russo, E.B. Beyond Cannabis: Plants and the Endocannabinoid System. Trends Pharmacol Sci. 2016 Jul;37(7):594-605. doi: 10.1016/j.tips.2016.04.005. Epub 2016 May 11. PubMed Link.
  10. Lu, H.C., and Mackie, K. An Introduction to the Endogenous Cannabinoid System. Biol Psychiatry. 2016;79(7):516-525.  doi:10.1016/j.biopsych.2015.07.028. PubMed Link.
  11. The Science of the Endocannabinoid System: How THC Affects the Brain and the Body. Scholastic. 2011. Link.
  12. Argenziano, M., Tortora, C., Bellini, G., Di Paola, A., Punzo, F., & Rossi, F. The Endocannabinoid System in Pediatric Inflammatory and Immune Diseases. 2019. 20(23), 5875. NCBI Link.
  13. Farokhnia, M., McDiarmid, G.R., Newmeyer, M.N., et al. Effects of oral, smoked, and vaporized cannabis on endocrine pathways related to appetite and metabolism: a randomized, double-blind, placebo-controlled, human laboratory study. Translational Psychiatry. 2020;10(1):71. Published 2020 Feb 19. ResearchGate Link.
  14. Russo, E.B. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal Pharmacology. 2011. ResearchGate Link.
  15. Mechoulam, R. Cannabis—A Valuable Drug That Deserves Better Treatment. Mayo Clinic Proceedings. Feb 2012. NCBI Link.
  16. Grotenhermen, F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42:327–360. PubMed Link.
  17. Sativex product monograph. 2010.

Product Information for Patients (Stella, Libra, Rosa)

  1. Hudson, Roger, et al. “Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1–2 Phosphorylation.” The Journal of Neuroscience, vol. 39, no. 44, 2019, pp. 8762–8777.
  2. Health Canada, 2018. Information for Health Care Professionals- Cannabis (marihuana, marijuana) and the cannabinoids.
  3. MacCallum, C.A, Russo, E.B. 2018. Practical Considerations in Medical Cannabis Administration and Dosing.

Kind Blog - Medicinal cannabis in Australia: what you need to know

  1. What does the history of Australian cannabis policy suggest about its likely future shape? Wayne D. Hall, The University of Queensland Centre for Clinical Research
  2. The History of Recreational Cannabis in Australia. Sydney Criminal Lawyers 2021